Lassa fever diagnostics: past, present, and future.

Africa, Western / epidemiology Antigens, Viral / immunology Clinical Laboratory Techniques / methods Genomics Humans Lassa Fever / diagnosis Lassa virus / genetics Molecular Diagnostic Techniques / methods Serologic Tests

Journal

Current opinion in virology
ISSN: 1879-6265
Titre abrégé: Curr Opin Virol
Pays: Netherlands
ID NLM: 101560941

Informations de publication

Date de publication:
08 2019
Historique:
received: 01 07 2019
accepted: 13 08 2019
pubmed: 14 9 2019
medline: 23 7 2020
entrez: 14 9 2019
Statut: ppublish

Résumé

Lassa fever is a unique viral hemorrhagic fever that is endemic in parts of West Africa, primarily Sierra Leone, Guinea, Liberia, and Nigeria. The disease is caused by the Lassa virus, an Old World arenavirus that has as primary reservoir host the multimammate rodent Mastomys nataliensis, which lives in association with humans. Recent estimates suggest LF causes two million cases and 5000-10000 deaths annually, mainly in West Africa. Clinical diagnosis and laboratory confirmation have always been major challenges for effective management and control of the disease in afflicted areas of West Africa. Recent advancements in molecular biology, recombinant DNA technology, and genomics sequencing has facilitated major advancement in development of better diagnostic and surveillance tools for Lassa fever virus. These include, the multiplex, magnetic bead-based immunodiagnostics for both Lassa virus antigens and antibodies; molecular probe-based quantitative real-time PCR for genomic signatures; rapid diagnostics tests that detects the most prevalent West African lineages; and the successful utilization of next-generation sequencing technology to diagnose and characterize Lassa virus in West Africa. These advances will continue to improve disease treatment, control, and prevention. In this review we will discuss progression of Lassa virus diagnostics from the past and into the future.

Identifiants

DOI: 10.1016/j.coviro.2019.08.002 PMID: 31518896 PMC: PMC6768724
pubmed: 31518896
pii: S1879-6257(19)30067-7
doi: 10.1016/j.coviro.2019.08.002
pmc: PMC6768724
mid: NIHMS1539598
pii:
doi:

Substances chimiques

Antigens, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-138

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG007480
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG007480
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R020116/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Virol J. 2016 Oct 3;13(1):163
pubmed: 27716429
mBio. 2012 Aug 14;3(4):e00180-12
pubmed: 22893382
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
J Clin Microbiol. 1994 Dec;32(12):2898-903
pubmed: 7883875
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003793
pubmed: 25996783
Bull World Health Organ. 1979;57(4):631-5
pubmed: 118812
Am J Trop Med Hyg. 1970 Jul;19(4):670-6
pubmed: 4246571
Am J Trop Med Hyg. 1993 Aug;49(2):214-21
pubmed: 8357084
Virol J. 2008 Jun 06;5:74
pubmed: 18538016
Sci Rep. 2018 Apr 12;8(1):5939
pubmed: 29651117
Viruses. 2012 Oct 09;4(10):2031-48
pubmed: 23202452
Virol J. 2011 Jun 20;8:314
pubmed: 21689444
Niger Med J. 2012 Oct;53(4):196-9
pubmed: 23661877
J Virol Methods. 2019 Aug;270:12-17
pubmed: 30998959
Philos Trans R Soc Lond B Biol Sci. 2012 Mar 19;367(1590):868-77
pubmed: 22312054
J Infect Dis. 2016 Oct 15;214(suppl 3):S222-S228
pubmed: 27443616
PLoS Negl Trop Dis. 2018 Mar 29;12(3):e0006361
pubmed: 29596412
Annu Rev Pathol. 2013 Jan 24;8:411-40
pubmed: 23121052
Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1253-64
pubmed: 17905372
J Virol. 2000 Aug;74(15):6992-7004
pubmed: 10888638
Emerg Infect Dis. 2010 Jul;16(7):1123-6
pubmed: 20587185
Nature. 1970 Jul 11;227(5254):174
pubmed: 5428406
Am J Trop Med Hyg. 2010 May;82(5):954-60
pubmed: 20439981
Curr Top Microbiol Immunol. 2002;262:75-109
pubmed: 11987809
J Clin Microbiol. 2010 Jun;48(6):2009-13
pubmed: 20351210
Viral Immunol. 2015 Feb;28(1):19-31
pubmed: 25531344
Antiviral Res. 2013 Dec;100(3):615-35
pubmed: 24129118
J Clin Microbiol. 2017 Jun;55(6):1629-1637
pubmed: 28404674
Am J Trop Med Hyg. 1970 Jul;19(4):680-91
pubmed: 4987547
Virol J. 2011 Oct 24;8:478
pubmed: 22023795
Nature. 2015 Dec 3;528(7580):S109-16
pubmed: 26633764
J Infect Dis. 1987 Mar;155(3):456-64
pubmed: 3805773
J Clin Microbiol. 1990 Dec;28(12):2689-92
pubmed: 2279999
J Clin Microbiol. 2000 Jul;38(7):2670-7
pubmed: 10878062
PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748
pubmed: 24651047
Front Microbiol. 2015 Oct 01;6:1037
pubmed: 26483768
J Clin Microbiol. 2016 Dec 28;55(1):68-78
pubmed: 27795340
Science. 1974 Jul 19;185(4147):263-5
pubmed: 4833828
Annu Rev Virol. 2017 Sep 29;4(1):141-158
pubmed: 28645238
N Engl J Med. 2018 Nov 1;379(18):1745-1753
pubmed: 30332564
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7320-7325
pubmed: 29941589
J Virol. 2015 Jul;89(14):7079-88
pubmed: 25926656
J Virol. 2015 Mar;89(5):2944-55
pubmed: 25552708
J Infect Dis. 1987 Mar;155(3):445-55
pubmed: 3805772
Cell. 2015 Aug 13;162(4):738-50
pubmed: 26276630
J Clin Microbiol. 2002 Jul;40(7):2323-30
pubmed: 12089242
Emerg Infect Dis. 2010 Jun;16(6):1041-3
pubmed: 20507774
N Engl J Med. 1986 Jan 2;314(1):20-6
pubmed: 3940312
Sci Rep. 2016 May 03;6:25280
pubmed: 27140942

Auteurs

Anise N Happi (AN)

Department of Veterinary Pathology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.

Christian T Happi (CT)

Department of Biological Sciences, College of Natural Sciences, Redeemer's University, Ede, Osun State, Nigeria; African center of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Osun State, Nigeria.

Randal J Schoepp (RJ)

U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA. Electronic address: randal.j.schoepp.civ@mail.mil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Afrique › Afrique subsaharienne › Afrique de l'Ouest › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes viraux › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Biologie › Génétique › Génomique › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Fièvres hémorragiques virales › Fièvre de Lassa › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN de polarité négative › Arenaviridae › Arenavirus › Arénavirus de l'Ancien Monde › Virus de Lassa › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Techniques de diagnostic moléculaire › Lassa fever diagnostics: past, present, and future.
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Tests sérologiques › Lassa fever diagnostics: past, present, and future.